Core Viewpoint - Huakang Clean achieved a significant increase in stock price and trading volume, indicating strong market interest and potential growth in the medical purification system sector [1][2]. Group 1: Financial Performance - For the first half of 2025, Huakang Clean reported revenue of 835 million yuan, representing a year-on-year growth of 50.73% [2]. - The net profit attributable to the parent company reached 18.68 million yuan, showing a substantial increase of 273.48% compared to the previous year [2]. - Cumulative cash dividends since the company's A-share listing amount to 40.02 million yuan, with 29.46 million yuan distributed over the past three years [3]. Group 2: Shareholder and Market Activity - As of September 19, the number of Huakang Clean's shareholders decreased by 2.96% to 10,000, while the average circulating shares per person increased by 3.05% to 7,272 shares [2]. - On September 25, Huakang Clean's financing buy-in amounted to 20.90 million yuan, with a net financing purchase of 1.18 million yuan, indicating strong investor interest [1]. - The total financing and securities balance reached 62.02 million yuan, accounting for 1.67% of the circulating market value, which is above the 90th percentile of the past year [1]. Group 3: Business Overview - Huakang Clean, established on November 12, 2008, specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1]. - The revenue composition of Huakang Clean includes 85.24% from purification system integration, 8.53% from medical consumables, 3.74% from medical equipment sales, and 1.88% from operation services [1]. Group 4: Institutional Holdings - As of June 30, 2025, notable institutional shareholders include Anxin Medical Health Stock A, which is the fifth largest shareholder with 652,800 shares, and Nuoan Multi-Strategy Mixed A, the tenth largest shareholder with 429,900 shares, both being new entrants [3].

Core Viewpoint - The stock of Huakang Clean has experienced fluctuations, with a year-to-date increase of 60.86% but a recent decline in the last five and twenty trading days [1][2]. Company Overview - Huakang Clean is based in Wuhan, Hubei Province, and was established on November 12, 2008, with its listing date on January 28, 2022. The company specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1]. - The revenue composition of Huakang Clean includes: 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation services, and 0.61% from other sources [1]. Financial Performance - For the first half of 2025, Huakang Clean achieved an operating income of 835 million yuan, representing a year-on-year growth of 50.73%. The net profit attributable to the parent company was 18.68 million yuan, showing a significant increase of 273.48% [2]. - Since its A-share listing, Huakang Clean has distributed a total of 40.02 million yuan in dividends, with 29.46 million yuan distributed over the past three years [3]. Shareholder Information - As of September 10, 2023, Huakang Clean had 10,300 shareholders, a decrease of 8.37% from the previous period. The average number of circulating shares per person increased by 9.14% to 7,056 shares [2]. - Notable institutional holdings include Anxin Medical Health Stock A as the fifth largest shareholder with 652,800 shares, and Nuoan Multi-Strategy Mixed A as the tenth largest shareholder with 429,900 shares, both being new shareholders [3].

分红方面，华康洁净A股上市后累计派现4002.14万元。近三年，累计派现2946.14万元。 机构持仓方面，截止2025年6月30日，华康洁净十大流通股东中，安信医药健康股票A（010709）位居 第五大流通股东，持股65.28万股，为新进股东。诺安多策略混合A（320016）位居第十大流通股东，持 股42.99万股，为新进股东。 责任编辑：小浪快报 融券方面，华康洁净9月15日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00元； 融券余量0.00股，融券余额0.00元，超过近一年70%分位水平，处于较高位。 资料显示，武汉华康世纪洁净科技股份有限公司位于湖北省武汉市东湖新技术开发区高新大道718号3 栋，成立日期2008年11月12日，上市日期2022年1月28日，公司主营业务涉及医疗净化系统研发、设 计、实施和运维,相关医疗设备和医疗耗材的销售。主营业务收入构成为：净化系统集成85.24%，医疗 耗材销售8.53%，医疗设备销售3.74%，运维服务1.88%，其他(补充)0.61%。 截至9月10日，华康洁净股东户数1.03万，较上期减少8.37%；人均流通股7056股，较上期增 ...

Core Viewpoint - Huakang Clean has shown significant stock performance and financial growth, indicating strong market interest and operational success in the medical purification sector [1][2]. Financial Performance - As of August 29, Huakang Clean achieved a revenue of 835 million yuan for the first half of 2025, representing a year-on-year growth of 50.73% [2]. - The net profit attributable to shareholders for the same period was 18.68 million yuan, marking a substantial increase of 273.48% year-on-year [2]. Stock Performance - The stock price of Huakang Clean increased by 69.49% year-to-date, with a recent rise of 3.26% over the last five trading days [1]. - The stock reached a price of 34.17 yuan per share, with a market capitalization of 3.682 billion yuan [1]. Shareholder Information - As of August 29, the number of shareholders increased to 11,200, reflecting a 3.20% rise from the previous period [2]. - The average number of circulating shares per shareholder decreased by 3.10% to 6,465 shares [2]. Dividend Distribution - Huakang Clean has distributed a total of 40.02 million yuan in dividends since its A-share listing, with 29.46 million yuan distributed over the past three years [3]. Institutional Holdings - As of June 30, 2025, notable institutional shareholders include Anxin Medical Health Stock A and Nuoan Multi-Strategy Mixed A, both of which are new entrants among the top ten circulating shareholders [3].

Group 1 - The core viewpoint of the news is that Huakang Clean has experienced a significant decline in stock price, with a 5.09% drop on September 4, leading to a cumulative decline of 11.04% over three consecutive days [1] - As of the report, Huakang Clean's stock price is at 31.90 yuan per share, with a trading volume of 1.23 billion yuan and a turnover rate of 5.10%, resulting in a total market capitalization of 34.38 billion yuan [1] - The company, established on November 12, 2008, specializes in the research, design, implementation, and operation of medical purification systems, with its main revenue sources being 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, and 1.88% from operation and maintenance services [1] Group 2 - From the perspective of Huakang Clean's top ten circulating shareholders, Noan Fund's Noan Multi-Strategy Mixed A (320016) has entered the top ten, holding 429,900 shares, which is 0.84% of the circulating shares [2] - The estimated floating loss for Noan Multi-Strategy Mixed A today is approximately 735,200 yuan, with a total floating loss of 1.79 million yuan during the three-day decline [2] - Noan Multi-Strategy Mixed A has achieved a return of 54.4% this year, ranking 527 out of 8,180 in its category, and a return of 110.3% over the past year, ranking 244 out of 7,978 [2] Group 3 - The fund managers of Noan Multi-Strategy Mixed A are Kong Xianzheng and Wang Haichang, with Kong having a tenure of 4 years and 283 days and a best fund return of 68.36% during his tenure [3] - Wang Haichang has a tenure of 3 years and 45 days, with a best fund return of 56.51% during his time managing the fund [3]